Cargando…

Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?

BACKGROUND: Cardiovascular disease (CVD) remains the major cause of excess mortality in patients with non-alcoholic fatty liver disease (NAFLD). The aim of this study was to investigate the individual contribution of NAFLD to CVD risk factors in the absence of pathogenic influences from other comorb...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeung, Emily N. W., Treskes, Philipp, Martin, Sarah F., Manning, Jonathan R., Dunbar, Donald R., Rogers, Sophie M., Le Bihan, Thierry, Lockman, K. Ann, Morley, Steven D., Hayes, Peter C., Nelson, Leonard J., Plevris, John N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529985/
https://www.ncbi.nlm.nih.gov/pubmed/26256740
http://dx.doi.org/10.1186/s12944-015-0069-3
_version_ 1782384854012264448
author Yeung, Emily N. W.
Treskes, Philipp
Martin, Sarah F.
Manning, Jonathan R.
Dunbar, Donald R.
Rogers, Sophie M.
Le Bihan, Thierry
Lockman, K. Ann
Morley, Steven D.
Hayes, Peter C.
Nelson, Leonard J.
Plevris, John N.
author_facet Yeung, Emily N. W.
Treskes, Philipp
Martin, Sarah F.
Manning, Jonathan R.
Dunbar, Donald R.
Rogers, Sophie M.
Le Bihan, Thierry
Lockman, K. Ann
Morley, Steven D.
Hayes, Peter C.
Nelson, Leonard J.
Plevris, John N.
author_sort Yeung, Emily N. W.
collection PubMed
description BACKGROUND: Cardiovascular disease (CVD) remains the major cause of excess mortality in patients with non-alcoholic fatty liver disease (NAFLD). The aim of this study was to investigate the individual contribution of NAFLD to CVD risk factors in the absence of pathogenic influences from other comorbidities often found in NAFLD patients, by using an established in-vitro model of hepatic steatosis. METHODS: Histopathological events in non-alcoholic fatty liver disease were recapitulated by focused metabolic nutrient overload of hepatoblastoma C3A cells, using oleate-treated-cells and untreated controls for comparison. Microarray and proteomic data from cell culture experiments were integrated into a custom-built systems biology database and proteogenomics analysis performed. Candidate genes with significant dysregulation and concomitant changes in protein abundance were identified and STRING association and enrichment analysis performed to identify putative pathogenic pathways. RESULTS: The search strategy yielded 3 candidate genes that were specifically and significantly up-regulated in nutrient-overloaded cells compared to untreated controls: fibrinogen alpha chain (2.2 fold), fibrinogen beta chain (2.3 fold) and fibrinogen gamma chain (2.1 fold) (all rank products pfp <0.05). Fibrinogen alpha and gamma chain also demonstrated significant concomitant increases in protein abundance (3.8-fold and 2.0-fold, respectively, p <0.05). CONCLUSIONS: In-vitro modelling of NAFLD and reactive oxygen species formation in nutrient overloaded C3A cells, in the absence of pathogenic influences from other comorbidities, suggests that NAFLD is an isolated determinant of CVD. Nutrient overload-induced up-regulation of all three fibrinogen component subunits of the coagulation cascade provides a possible mechanism to explain the excess CVD mortality observed in NAFLD patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12944-015-0069-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4529985
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45299852015-08-10 Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events? Yeung, Emily N. W. Treskes, Philipp Martin, Sarah F. Manning, Jonathan R. Dunbar, Donald R. Rogers, Sophie M. Le Bihan, Thierry Lockman, K. Ann Morley, Steven D. Hayes, Peter C. Nelson, Leonard J. Plevris, John N. Lipids Health Dis Research BACKGROUND: Cardiovascular disease (CVD) remains the major cause of excess mortality in patients with non-alcoholic fatty liver disease (NAFLD). The aim of this study was to investigate the individual contribution of NAFLD to CVD risk factors in the absence of pathogenic influences from other comorbidities often found in NAFLD patients, by using an established in-vitro model of hepatic steatosis. METHODS: Histopathological events in non-alcoholic fatty liver disease were recapitulated by focused metabolic nutrient overload of hepatoblastoma C3A cells, using oleate-treated-cells and untreated controls for comparison. Microarray and proteomic data from cell culture experiments were integrated into a custom-built systems biology database and proteogenomics analysis performed. Candidate genes with significant dysregulation and concomitant changes in protein abundance were identified and STRING association and enrichment analysis performed to identify putative pathogenic pathways. RESULTS: The search strategy yielded 3 candidate genes that were specifically and significantly up-regulated in nutrient-overloaded cells compared to untreated controls: fibrinogen alpha chain (2.2 fold), fibrinogen beta chain (2.3 fold) and fibrinogen gamma chain (2.1 fold) (all rank products pfp <0.05). Fibrinogen alpha and gamma chain also demonstrated significant concomitant increases in protein abundance (3.8-fold and 2.0-fold, respectively, p <0.05). CONCLUSIONS: In-vitro modelling of NAFLD and reactive oxygen species formation in nutrient overloaded C3A cells, in the absence of pathogenic influences from other comorbidities, suggests that NAFLD is an isolated determinant of CVD. Nutrient overload-induced up-regulation of all three fibrinogen component subunits of the coagulation cascade provides a possible mechanism to explain the excess CVD mortality observed in NAFLD patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12944-015-0069-3) contains supplementary material, which is available to authorized users. BioMed Central 2015-08-10 /pmc/articles/PMC4529985/ /pubmed/26256740 http://dx.doi.org/10.1186/s12944-015-0069-3 Text en © Yeung et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Yeung, Emily N. W.
Treskes, Philipp
Martin, Sarah F.
Manning, Jonathan R.
Dunbar, Donald R.
Rogers, Sophie M.
Le Bihan, Thierry
Lockman, K. Ann
Morley, Steven D.
Hayes, Peter C.
Nelson, Leonard J.
Plevris, John N.
Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?
title Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?
title_full Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?
title_fullStr Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?
title_full_unstemmed Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?
title_short Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?
title_sort fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529985/
https://www.ncbi.nlm.nih.gov/pubmed/26256740
http://dx.doi.org/10.1186/s12944-015-0069-3
work_keys_str_mv AT yeungemilynw fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents
AT treskesphilipp fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents
AT martinsarahf fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents
AT manningjonathanr fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents
AT dunbardonaldr fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents
AT rogerssophiem fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents
AT lebihanthierry fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents
AT lockmankann fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents
AT morleystevend fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents
AT hayespeterc fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents
AT nelsonleonardj fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents
AT plevrisjohnn fibrinogenproductionisenhancedinaninvitromodelofnonalcoholicfattyliverdiseaseanisolatedriskfactorforcardiovascularevents